相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson et al.
CANCER RESEARCH (2021)
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study
Nehal J. Lakhani et al.
LANCET ONCOLOGY (2021)
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
Christopher Sloas et al.
FRONTIERS IN IMMUNOLOGY (2021)
CAR-macrophage: A new immunotherapy candidate against solid tumors
Yizhao Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization
Guolong Xu et al.
ONCOGENE (2020)
Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma
Yingnan Ye et al.
CANCER LETTERS (2020)
Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP
Yi Zhou et al.
IMMUNITY (2020)
MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity
Renumathy Dhanasekaran et al.
ELIFE (2020)
RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis
Lei Wu et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
Yang Yang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization
Xiaoping Zhao et al.
EXPERIMENTAL CELL RESEARCH (2020)
Tumor-Associated Macrophage Status in Cancer Treatment
Anna Maria Malfitano et al.
CANCERS (2020)
Telomeres and Telomerase in the Development of Liver Cancer
Lena in der Stroth et al.
CANCERS (2020)
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Yuqiong Xia et al.
ADVANCED MATERIALS (2020)
Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma
Zhao-Shan Niu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Self-enforcing HMGB1/NF-κB/HIF-1α Feedback Loop Promotes Cisplatin Resistance in Hepatocellular Carcinoma Cells
Yang Song et al.
JOURNAL OF CANCER (2020)
Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
Xiu-Tao Fu et al.
CANCER CELL INTERNATIONAL (2019)
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
Ying Zhu et al.
GUT (2019)
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages
C. A. Gomez-Roca et al.
ANNALS OF ONCOLOGY (2019)
M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma
Ningning Dong et al.
BRITISH JOURNAL OF CANCER (2019)
Individualized precision treatment: Targeting TAM in HCC
Zhixuan Li et al.
CANCER LETTERS (2019)
Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma
Xiuqi Wu et al.
MOLECULAR THERAPY (2019)
SIRT1 inhibits hepatocellular carcinoma metastasis by promoting M1 macrophage polarization via NF-κB pathway
Bei Zhou et al.
ONCOTARGETS AND THERAPY (2019)
Interaction of transforming growth factor-β-Smads/microRNA-362-3p/CD82 mediated by M2 macrophages promotes the process of epithelial-mesenchymal transition in hepatocellular carcinoma cells
Qinghui Zhang et al.
CANCER SCIENCE (2019)
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Yaojie Fu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells
Yahima Frion-Herrera et al.
LIFE SCIENCES (2019)
Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis
Wei Ding et al.
PLOS ONE (2019)
MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis
Mengyun Ke et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90
Yufeng Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Nanotechnology in cancer diagnosis: progress, challenges and opportunities
Ye Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
Daphne van der Heide et al.
FRONTIERS IN IMMUNOLOGY (2019)
The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers
Matthias Bartneck et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
Marina Martinez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma
Changzhou Cai et al.
JOURNAL OF CANCER (2019)
Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy
Tianqi Wang et al.
NANOSCALE (2019)
MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10
Lei Li et al.
BIOCHIMIE (2018)
Fatty acid oxidation contributes to IL-1β secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration
Qi Zhang et al.
MOLECULAR IMMUNOLOGY (2018)
M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway
Rong-Rong Yao et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition
Yongxu Chen et al.
ONCOTARGETS AND THERAPY (2018)
Chimeric antigen receptors that trigger phagocytosis
Meghan A. Morrissey et al.
ELIFE (2018)
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
Masahiro Matsuki et al.
CANCER MEDICINE (2018)
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Tart Cherry Reduces Inflammation in Adipose Tissue of Zucker Fatty Rats and Cultured 3T3-L1 Adipocytes
Shasika Jayarathne et al.
NUTRIENTS (2018)
A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment
Yu-Tzu Liu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Tumor Molecular Profiling for an Individualized Approach to the Treatment of Hepatocellular Carcinoma: A Patient Case Study
Kristine Posadas et al.
BIOMEDICINES (2018)
Comprehensive Proteomics Analysis Reveals Metabolic Reprogramming of Tumor-Associated Macrophages Stimulated by the Tumor Microenvironment
Di Liu et al.
JOURNAL OF PROTEOME RESEARCH (2017)
PI3Kγ is a molecular switch that controls immune suppression (vol 539, pg 437, 2016)
Megan M. Kaneda et al.
NATURE (2017)
Cancer immunotherapy targeting the CD47/SIRPα axis
Kipp Weiskopf
EUROPEAN JOURNAL OF CANCER (2017)
Chronic Inflammation-Elicited Liver Progenitor Cell Conversion to Liver Cancer Stem Cell With Clinical Significance
Xiao-Feng Li et al.
HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma
Jian-Yang Ao et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Hypoxia inducible factors in hepatocellular carcinoma
Chu Chen et al.
ONCOTARGET (2017)
Anti-GPEC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenogratfts of Hepatocelluar Carcinoma
Zhiwu Jiang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma
Hao Cai et al.
ONCOIMMUNOLOGY (2017)
A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
Wenbo Yao et al.
EBIOMEDICINE (2017)
A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+hepatocellular carcinoma (r/r GPC3+HCC).
Bo Zhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cabozantinib: Mechanism of action, efficacy and indications
Valerie Cochin et al.
BULLETIN DU CANCER (2017)
Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis
Eunee Koh et al.
BIOMATERIALS (2017)
The Warburg effect: 80 years on
Michelle Potter et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway
Jie Mao et al.
CANCER LETTERS (2016)
Inhibiting macrophage PI3Kγ to enhance immunotherapy
Wei Zheng et al.
CELL RESEARCH (2016)
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Jaehong Kim et al.
MEDIATORS OF INFLAMMATION (2016)
CAR T cells ready to go mainstream
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
Eric Lefebvre et al.
PLOS ONE (2016)
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
Zhenyu Xiao et al.
CANCER LETTERS (2015)
Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages
Wenjiang Yan et al.
GUT (2015)
CXCR4 Inhibition in Tumor Microenvironment Facilitates Anti-Programmed Death Receptor-1 Immunotherapy in Sorafenib-Treated Hepatocellular Carcinoma in Mice
Yunching Chen et al.
HEPATOLOGY (2015)
Chemokine (C-X-C Motif) Receptor 3-Positive B Cells Link Interleukin-17 Inflammation to Protumorigenic Macrophage Polarization in Human Hepatocellular Carcinoma
Rui-Xian Liu et al.
HEPATOLOGY (2015)
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study
Philippe A. Cassier et al.
LANCET ONCOLOGY (2015)
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2015)
Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin
H-Y Tan et al.
CELL DEATH & DISEASE (2015)
MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma
Xufu Wei et al.
ONCOTARGET (2015)
Current Concept and Update of the Macrophage Plasticity Concept: Intracellular Mechanisms of Reprogramming and M3 Macrophage Switch Phenotype
Igor Malyshev et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma
Qing-Min Fan et al.
CANCER LETTERS (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
Shanshan Wan et al.
GASTROENTEROLOGY (2014)
Cantharidin Exerts Anti-Hepatocellular Carcinoma by Mir-214 Modulating Macrophage Polarization
Sen Lu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells
Jian Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Role of tumor-associated macrophages in the angiogenesis of well-differentiated hepatocellular carcinoma: Pathological-radiological correlation
Nobuhiro Fujita et al.
ONCOLOGY REPORTS (2014)
Targeting NFKB by autophagy to polarize hepatoma-associated macrophage differentiation
Chih-Peng Chang et al.
AUTOPHAGY (2013)
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
Martin Franz Sprinzl et al.
HEPATOLOGY (2013)
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications
Mark P. Chao et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008
Sean F. Altekruse et al.
HEPATOLOGY (2012)
Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy
Zhen Huang et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
Wei Zhang et al.
CLINICAL CANCER RESEARCH (2010)
Phosphoinositide-Dependent Kinase 1 Provides Negative Feedback Inhibition to Toll-Like Receptor-Mediated NF-κB Activation in Macrophages
Bhagirath Chaurasia et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Macrophages and Inflammatory Mediators in Chemical Toxicity: A Battle of Forces
Debra L. Laskin
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma
Xiao-Dong Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)
分享论文
